Zhang et al. found that alpha-1-acid glycoprotein (AGP1) glycopeptides had significantly higher glycan branching, sialylation, and fucosylation in samples from NASH and cirrhosis patients compared to controls. This evidence concerns the gene ORM1 and metabolic dysfunction-associated steatohepatitis.